Standout Papers

Incidence and impact of subclinical epileptiform activity in Alzheimer's disease 2016 2026 2019 2022 343
  1. Incidence and impact of subclinical epileptiform activity in Alzheimer's disease (2016)
    Keith Vossel, Kamalini G. Ranasinghe et al. Annals of Neurology
  2. Effect of Levetiracetam on Cognition in Patients With Alzheimer Disease With and Without Epileptiform Activity (2021)
    Keith Vossel, Kamalini G. Ranasinghe et al. JAMA Neurology

Immediate Impact

1 by Nobel laureates 2 from Science/Nature 59 standout
Sub-graph 1 of 21

Citing Papers

A foundation model for clinician-centered drug repurposing
2024 Standout
Epilepsy and epileptiform activity in late-onset Alzheimer disease: clinical and pathophysiological advances, gaps and conundrums
2024 Standout
1 intermediate paper

Works of Danielle Mizuiri being referenced

Effect of Levetiracetam on Cognition in Patients With Alzheimer Disease With and Without Epileptiform Activity
2021 Standout
Neuronal synchrony abnormalities associated with subclinical epileptiform activity in early-onset Alzheimer’s disease
2021
and 2 more

Author Peers

Author Last Decade Papers Cites
Danielle Mizuiri 1325 644 124 416 51 2.1k
Susanne Honma 1200 497 26 391 29 2.0k
Nasim Maleki 833 1439 152 188 49 2.5k
Yihong Yang 1517 616 34 421 79 2.7k
Gao‐Jun Teng 1470 380 289 224 71 3.0k
Paul L. Furlong 1559 262 69 342 68 2.5k
Katherine E. Prater 2109 439 88 259 23 3.1k
Goran Vučurević 1053 588 49 185 63 2.1k
Robin L. Gilmore 1262 746 34 422 80 2.7k
Jee Hoon Roh 1216 641 42 469 72 2.9k
Caroline Hommet 682 850 200 385 101 2.3k

All Works

Loading papers...

Rankless by CCL
2026